In TRIM37‐amplified tumours (such as neuroblastoma and breast cancer), PLK4 inhibition induces centrosomal dysfunction and mitotic abnormalities, ultimately leading to cell death—a synthetic lethal effect. This evidence concerns the gene PLK4 and breast cancer.